- What is the role of cross-border collaboration?
- What are the main pillars of the new MVA strategy?
- To what extent can the Medicon Valley Alliance model contribute to broader European competitiveness?
These are some of the questions asked and answered in the interview published yesterday in PHARMA Boardroom. We hope you will enjoy the reading!
Cliffhanger! The latter question will also be the focus point for this year´s MVA Annual Summit 10th of November, which will be announced shortly. You can, however, save the date already.